REQUEST A DEMO
Total
USD $0.00
Search more companies

Miedzynarodowy Instytut Medycyny Translacyjnej (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Dog and Cat Food Manufacturing | Other Animal Food Manufacturing | Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Manufacturing | All Other General Merchandise Stores | Other Direct Selling Establishments | Lessors of Real Estate | Colleges, Universities, and Professional Schools
Full name: Miedzynarodowy Instytut Medycyny Translacyjnej Profile Updated: May 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Miedzynarodowy Instytut Medycyny Translacyjnej is an enterprise located in Poland, with the main office in Wroclaw. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on February 25, 2019. From the latest financial highlights, Miedzynarodowy Instytut Medycyny Translacyjnej reported a net sales revenue increase of 7500% in 2022. Its total assets grew by 28.95% over the same period. The net profit margin of Miedzynarodowy Instytut Medycyny Translacyjnej decreased by 101685.51% in 2022.

Headquarters
Ul. Dunska 7
Wroclaw; Dolnoslaskie; Postal Code: 50-001

Contact Details: Purchase the Miedzynarodowy Instytut Medycyny Translacyjnej report to view the information.

Basic Information
Outstanding Shares:
Purchase the Miedzynarodowy Instytut Medycyny Translacyjnej report to view the information.
Incorporation Date:
February 25, 2019
Key Executives
Purchase this report to view the information.
Vice President
Company Performance
Financial values in the chart are available after Miedzynarodowy Instytut Medycyny Translacyjnej report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
7500%
Total operating revenue
-27.79%
Operating profit (EBIT)
-78.5%
Net Profit (Loss) for the Period
-78.48%
Total assets
28.95%
Total equity
21.29%
Operating Profit Margin (ROS)
-101925.24%
Net Profit Margin
-101685.51%
Return on Equity (ROE)
-81.38%
Quick Ratio
-184.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?